Categories: DesignDrugInformationPlatform
QuanMol Tech is establishing a new standard for in-silico drug discovery with its AI-powered precision drug design platform that determines optimal compounds from structural information over traditional trial-and-error based processes.
Investors 1
Mentions in press and media 1
| Date | Title | Description |
| 05.02.2023 | QuanMol Tech Announces $3M Seed Funding This Month | New York, New York--(Newsfile Corp. - February 4, 2023) - QuanMol Tech, a technology company specializing in the integration of AI in molecular design, has announced that it has received $3 million in seed funding. The company aims to impro... |
Reviews 0
